PDS Biotech Appoints Lars Boesgaard as Chief Financial Officer

November 28, 2023

https://www.globenewswire.com/news-release/2023/11/28/2786835/37149/en/PDS-Biotech-Appoints-Lars-Boesgaard-as-Chief-Financial-Officer.html

PRINCETON, N.J., Nov. 28, 2023 (GLOBE NEWSWIRE) — PDS Biotechnology Corporation (Nasdaq:PDSB) (“PDS Biotech” or the “Company”), a clinical-stage immunotherapy company developing a growing pipeline of targeted cancer immunotherapies and infectious disease vaccines based on the Company’s proprietary T cell activating platforms, today announced the appointment of Lars Boesgaard as Chief Financial Officer (CFO), effective as of December 4, 2023. Mr. Boesgaard succeeds Matthew Hill, who resigned as PDS Biotech’s CFO on November 21, 2023, effective December 1, 2023, to pursue other professional endeavors.

Read more at globenewswire.com

Related news for (PDSB)

PDS Biotech Appoints Lars Boesgaard as Chief Financial Officer

November 28, 2023

https://www.globenewswire.com/news-release/2023/11/28/2786835/37149/en/PDS-Biotech-Appoints-Lars-Boesgaard-as-Chief-Financial-Officer.html

PRINCETON, N.J., Nov. 28, 2023 (GLOBE NEWSWIRE) — PDS Biotechnology Corporation (Nasdaq:PDSB) (“PDS Biotech” or the “Company”), a clinical-stage immunotherapy company developing a growing pipeline of targeted cancer immunotherapies and infectious disease vaccines based on the Company’s proprietary T cell activating platforms, today announced the appointment of Lars Boesgaard as Chief Financial Officer (CFO), effective as of December 4, 2023. Mr. Boesgaard succeeds Matthew Hill, who resigned as PDS Biotech’s CFO on November 21, 2023, effective December 1, 2023, to pursue other professional endeavors.

Read more at globenewswire.com

Related news for (PDSB)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.